Roche Translational Cancer Research Fellowship

Since 2016, Roche has been partnering with the New Zealand Society for Oncology (NZSO) to award the Roche Translational Cancer Research Fellowship to an annual value of $30,000.

Both Roche and NZSO recognise the importance of keeping up-to-date with international developments in cancer research and oncology clinical practice.

Translational research bridges the gap from basic science in the lab to clinical practice, in order to enhance human health and well-being. It’s sometimes referred to as bench to bedside to community. Research is most effective when clinicians and scientists work together and a key role of NZSO is to encourage collaboration between clinicians and scientists.

This award provides a unique opportunity for NZ cancer research teams to upskill an integral team member, so that the team can work together more effectively and improve research output.

Please click here to download full details on eligibility, favoured recipients and requirements.

To apply for the award please send the CV of the team recipient, along with a one page proposal that includes details on the team, how the team proposes to use the funds and how the proposed activity would improve the output of the team to All applications must be received by Friday 27 August.

Past winners

New Zealand Society for Oncology Translational Research Award

The 2021 New Zealand Society for Oncology Conference organising committee are now calling for nominations for the NZSO Translational Research Award.

This award recognises exceptional career achievement in translational cancer research and is selected from nominations solicited from the scientific and medical community.

The recipient will receive a cash prize of $5,000 and will be asked to present a 30 minute lecture at the 2021 conference.

The selection committee will consist of three professorial and senior consultant-level assessors, and will be chaired ex officio by the President-Elect of the NZSO.

To submit a nomination, please send a brief citation statement to by 27 August 2021.

PHARMAC Emerging Researcher Awards

This is an award for the best presentation by a trainee or young member of the Society at the Conference. The cash prize is intended to advance the recipient's career in Oncology, but within this guideline the recipient is free to use this award as desired.

Emerging Researcher Award - clinical

Emerging Researcher Award – biomedical

Those eligible for the prize are students in scientific or medical disciplines or allied fields and trainee clinicians. If no suitable person is identified, and at the discretion of the Judging Committee, the prize may be awarded to a member of the Society who is in their first 5 years out of study. The Judging Committee will consist of two consultant oncologists and two professorial scientists. The decision of the panel is final.

Applications for this award are to be submitted as part of the call for abstracts process. Call for abstracts close 2 August 2021.